Table of Content

1 Recombinant Human Follitropin Market Overview
1.1 Product Overview and Scope of Recombinant Human Follitropin
1.2 Recombinant Human Follitropin Segment by Type
1.2.1 Global Recombinant Human Follitropin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 RHF-α
1.2.3 RHF-β
1.2.4 Urofollitropin
1.3 Recombinant Human Follitropin Segment by Application
1.3.1 Recombinant Human Follitropin Sales Comparison by Application: (2021-2027)
1.3.2 Freeze-Dried Powder Injection
1.3.3 Injection
1.4 Global Recombinant Human Follitropin Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Follitropin Revenue 2016-2027
1.4.2 Global Recombinant Human Follitropin Sales 2016-2027
1.4.3 Recombinant Human Follitropin Market Size by Region: 2016 Versus 2021 Versus 2027

2 Recombinant Human Follitropin Market Competition by Manufacturers
2.1 Global Recombinant Human Follitropin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Recombinant Human Follitropin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Recombinant Human Follitropin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Recombinant Human Follitropin Manufacturing Sites, Area Served, Product Type
2.5 Recombinant Human Follitropin Market Competitive Situation and Trends
2.5.1 Recombinant Human Follitropin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Recombinant Human Follitropin Players Market Share by Revenue
2.5.3 Global Recombinant Human Follitropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Recombinant Human Follitropin Retrospective Market Scenario by Region
3.1 Global Recombinant Human Follitropin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Recombinant Human Follitropin Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Recombinant Human Follitropin Market Facts & Figures by Country
3.3.1 North America Recombinant Human Follitropin Sales by Country
3.3.2 North America Recombinant Human Follitropin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Recombinant Human Follitropin Market Facts & Figures by Country
3.4.1 Europe Recombinant Human Follitropin Sales by Country
3.4.2 Europe Recombinant Human Follitropin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Recombinant Human Follitropin Market Facts & Figures by Region
3.5.1 Asia Pacific Recombinant Human Follitropin Sales by Region
3.5.2 Asia Pacific Recombinant Human Follitropin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Recombinant Human Follitropin Market Facts & Figures by Country
3.6.1 Latin America Recombinant Human Follitropin Sales by Country
3.6.2 Latin America Recombinant Human Follitropin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Recombinant Human Follitropin Market Facts & Figures by Country
3.7.1 Middle East and Africa Recombinant Human Follitropin Sales by Country
3.7.2 Middle East and Africa Recombinant Human Follitropin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Recombinant Human Follitropin Historic Market Analysis by Type
4.1 Global Recombinant Human Follitropin Sales Market Share by Type (2016-2021)
4.2 Global Recombinant Human Follitropin Revenue Market Share by Type (2016-2021)
4.3 Global Recombinant Human Follitropin Price by Type (2016-2021)

5 Global Recombinant Human Follitropin Historic Market Analysis by Application
5.1 Global Recombinant Human Follitropin Sales Market Share by Application (2016-2021)
5.2 Global Recombinant Human Follitropin Revenue Market Share by Application (2016-2021)
5.3 Global Recombinant Human Follitropin Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Changchun High & New
6.1.1 Changchun High & New Corporation Information
6.1.2 Changchun High & New Description and Business Overview
6.1.3 Changchun High & New Recombinant Human Follitropin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Changchun High & New Product Portfolio
6.1.5 Changchun High & New Recent Developments/Updates
6.2 Merck Serono
6.2.1 Merck Serono Corporation Information
6.2.2 Merck Serono Description and Business Overview
6.2.3 Merck Serono Recombinant Human Follitropin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Serono Product Portfolio
6.2.5 Merck Serono Recent Developments/Updates
6.3 Merck(USA)
6.3.1 Merck(USA) Corporation Information
6.3.2 Merck(USA) Description and Business Overview
6.3.3 Merck(USA) Recombinant Human Follitropin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck(USA) Product Portfolio
6.3.5 Merck(USA) Recent Developments/Updates
6.4 Gen Sci
6.4.1 Gen Sci Corporation Information
6.4.2 Gen Sci Description and Business Overview
6.4.3 Gen Sci Recombinant Human Follitropin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Gen Sci Product Portfolio
6.4.5 Gen Sci Recent Developments/Updates
6.5 LIVZON
6.5.1 LIVZON Corporation Information
6.5.2 LIVZON Description and Business Overview
6.5.3 LIVZON Recombinant Human Follitropin Sales, Revenue and Gross Margin (2016-2021)
6.5.4 LIVZON Product Portfolio
6.5.5 LIVZON Recent Developments/Updates
6.6 IBSA
6.6.1 IBSA Corporation Information
6.6.2 IBSA Description and Business Overview
6.6.3 IBSA Recombinant Human Follitropin Sales, Revenue and Gross Margin (2016-2021)
6.6.4 IBSA Product Portfolio
6.6.5 IBSA Recent Developments/Updates
6.7 Reproductive Health
6.6.1 Reproductive Health Corporation Information
6.6.2 Reproductive Health Description and Business Overview
6.6.3 Reproductive Health Recombinant Human Follitropin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Reproductive Health Product Portfolio
6.7.5 Reproductive Health Recent Developments/Updates
6.8 Ferring
6.8.1 Ferring Corporation Information
6.8.2 Ferring Description and Business Overview
6.8.3 Ferring Recombinant Human Follitropin Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Ferring Product Portfolio
6.8.5 Ferring Recent Developments/Updates

7 Recombinant Human Follitropin Manufacturing Cost Analysis
7.1 Recombinant Human Follitropin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Recombinant Human Follitropin
7.4 Recombinant Human Follitropin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Recombinant Human Follitropin Distributors List
8.3 Recombinant Human Follitropin Customers

9 Recombinant Human Follitropin Market Dynamics
9.1 Recombinant Human Follitropin Industry Trends
9.2 Recombinant Human Follitropin Growth Drivers
9.3 Recombinant Human Follitropin Market Challenges
9.4 Recombinant Human Follitropin Market Restraints

10 Global Market Forecast
10.1 Recombinant Human Follitropin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Recombinant Human Follitropin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Recombinant Human Follitropin by Type (2022-2027)
10.2 Recombinant Human Follitropin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Recombinant Human Follitropin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Recombinant Human Follitropin by Application (2022-2027)
10.3 Recombinant Human Follitropin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Recombinant Human Follitropin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Recombinant Human Follitropin by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Recombinant Human Follitropin Sales (Kg) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Recombinant Human Follitropin Sales (Kg) Comparison by Application (2021-2027)
Table 3. Global Recombinant Human Follitropin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Recombinant Human Follitropin Covered in This Study
Table 5. Global Recombinant Human Follitropin Sales (Kg) of Key Manufacturers (2016-2021)
Table 6. Global Recombinant Human Follitropin Sales Share by Manufacturers (2016-2021)
Table 7. Global Recombinant Human Follitropin Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Recombinant Human Follitropin Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Recombinant Human Follitropin Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Recombinant Human Follitropin Manufacturing Sites and Area Served
Table 11. Manufacturers Recombinant Human Follitropin Product Type
Table 12. Global Recombinant Human Follitropin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Recombinant Human Follitropin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Follitropin as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Recombinant Human Follitropin Sales by Region (2016-2021) & (Kg)
Table 16. Global Recombinant Human Follitropin Sales Market Share by Region (2016-2021)
Table 17. Global Recombinant Human Follitropin Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Recombinant Human Follitropin Sales by Country (2016-2021) & (Kg)
Table 19. North America Recombinant Human Follitropin Sales Market Share by Country (2016-2021)
Table 20. North America Recombinant Human Follitropin Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Recombinant Human Follitropin Revenue Market Share by Country (2016-2021)
Table 22. Europe Recombinant Human Follitropin Sales by Country (2016-2021) & (Kg)
Table 23. Europe Recombinant Human Follitropin Sales Market Share by Country (2016-2021)
Table 24. Europe Recombinant Human Follitropin Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Recombinant Human Follitropin Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Recombinant Human Follitropin Sales by Region (2016-2021) & (Kg)
Table 27. Asia Pacific Recombinant Human Follitropin Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Recombinant Human Follitropin Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Recombinant Human Follitropin Revenue Market Share by Region (2016-2021)
Table 30. Latin America Recombinant Human Follitropin Sales by Country (2016-2021) & (Kg)
Table 31. Latin America Recombinant Human Follitropin Sales Market Share by Country (2016-2021)
Table 32. Latin America Recombinant Human Follitropin Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Recombinant Human Follitropin Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Recombinant Human Follitropin Sales by Country (2016-2021) & (Kg)
Table 35. Middle East and Africa Recombinant Human Follitropin Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Recombinant Human Follitropin Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Recombinant Human Follitropin Revenue Market Share by Country (2016-2021)
Table 38. Global Recombinant Human Follitropin Sales (Kg) by Type (2016-2021)
Table 39. Global Recombinant Human Follitropin Sales Market Share by Type (2016-2021)
Table 40. Global Recombinant Human Follitropin Revenue (Million US$) by Type (2016-2021)
Table 41. Global Recombinant Human Follitropin Revenue Share by Type (2016-2021)
Table 42. Global Recombinant Human Follitropin Price (USD/Kg) by Type (2016-2021)
Table 43. Global Recombinant Human Follitropin Sales (Kg) by Application (2016-2021)
Table 44. Global Recombinant Human Follitropin Sales Market Share by Application (2016-2021)
Table 45. Global Recombinant Human Follitropin Revenue (Million US$) by Application (2016-2021)
Table 46. Global Recombinant Human Follitropin Revenue Share by Application (2016-2021)
Table 47. Global Recombinant Human Follitropin Price (USD/Kg) by Application (2016-2021)
Table 48. Changchun High & New Corporation Information
Table 49. Changchun High & New Description and Business Overview
Table 50. Changchun High & New Recombinant Human Follitropin Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. Changchun High & New Recombinant Human Follitropin Product
Table 52. Changchun High & New Recent Developments/Updates
Table 53. Merck Serono Corporation Information
Table 54. Merck Serono Description and Business Overview
Table 55. Merck Serono Recombinant Human Follitropin Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. Merck Serono Recombinant Human Follitropin Product
Table 57. Merck Serono Recent Developments/Updates
Table 58. Merck(USA) Corporation Information
Table 59. Merck(USA) Description and Business Overview
Table 60. Merck(USA) Recombinant Human Follitropin Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. Merck(USA) Recombinant Human Follitropin Product
Table 62. Merck(USA) Recent Developments/Updates
Table 63. Gen Sci Corporation Information
Table 64. Gen Sci Description and Business Overview
Table 65. Gen Sci Recombinant Human Follitropin Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. Gen Sci Recombinant Human Follitropin Product
Table 67. Gen Sci Recent Developments/Updates
Table 68. LIVZON Corporation Information
Table 69. LIVZON Description and Business Overview
Table 70. LIVZON Recombinant Human Follitropin Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. LIVZON Recombinant Human Follitropin Product
Table 72. LIVZON Recent Developments/Updates
Table 73. IBSA Corporation Information
Table 74. IBSA Description and Business Overview
Table 75. IBSA Recombinant Human Follitropin Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. IBSA Recombinant Human Follitropin Product
Table 77. IBSA Recent Developments/Updates
Table 78. Reproductive Health Corporation Information
Table 79. Reproductive Health Description and Business Overview
Table 80. Reproductive Health Recombinant Human Follitropin Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 81. Reproductive Health Recombinant Human Follitropin Product
Table 82. Reproductive Health Recent Developments/Updates
Table 83. Ferring Corporation Information
Table 84. Ferring Description and Business Overview
Table 85. Ferring Recombinant Human Follitropin Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 86. Ferring Recombinant Human Follitropin Product
Table 87. Ferring Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Recombinant Human Follitropin Distributors List
Table 91. Recombinant Human Follitropin Customers List
Table 92. Recombinant Human Follitropin Market Trends
Table 93. Recombinant Human Follitropin Growth Drivers
Table 94. Recombinant Human Follitropin Market Restraints
Table 95. Global Recombinant Human Follitropin Sales Forecast by Type (2022-2027) & (Kg)
Table 96. Global Recombinant Human Follitropin Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Recombinant Human Follitropin Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Recombinant Human Follitropin Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Recombinant Human Follitropin Sales Forecast by Application (2022-2027) & (Kg)
Table 100. Global Recombinant Human Follitropin Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Recombinant Human Follitropin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Recombinant Human Follitropin Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Recombinant Human Follitropin Sales Forecast by Region (2022-2027) & (Kg)
Table 104. Global Recombinant Human Follitropin Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Recombinant Human Follitropin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Recombinant Human Follitropin Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant Human Follitropin
Figure 2. Global Recombinant Human Follitropin Market Share by Type in 2020 & 2027
Figure 3. RHF-α Product Picture
Figure 4. RHF-β Product Picture
Figure 5. Urofollitropin Product Picture
Figure 6. Global Recombinant Human Follitropin Market Share by Application in 2020 & 2027
Figure 7. Freeze-Dried Powder Injection
Figure 8. Injection
Figure 9. Global Recombinant Human Follitropin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Recombinant Human Follitropin Market Size 2016-2027 (US$ Million)
Figure 11. Global Recombinant Human Follitropin Sales 2016-2027 (Kg)
Figure 12. Global Recombinant Human Follitropin Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Recombinant Human Follitropin Sales Share by Manufacturers in 2020
Figure 14. Global Recombinant Human Follitropin Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Recombinant Human Follitropin Players: Market Share by Revenue in 2020
Figure 16. Recombinant Human Follitropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Recombinant Human Follitropin Sales Market Share by Region (2016-2021)
Figure 18. Global Recombinant Human Follitropin Sales Market Share by Region in 2020
Figure 19. Global Recombinant Human Follitropin Revenue Market Share by Region (2016-2021)
Figure 20. Global Recombinant Human Follitropin Revenue Market Share by Region in 2020
Figure 21. U.S. Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Recombinant Human Follitropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Recombinant Human Follitropin by Type (2016-2021)
Figure 46. Sales Market Share of Recombinant Human Follitropin by Application (2016-2021)
Figure 47. Sales Market Share of Recombinant Human Follitropin by Application in 2020
Figure 48. Revenue Share of Recombinant Human Follitropin by Application (2016-2021)
Figure 49. Revenue Share of Recombinant Human Follitropin by Application in 2020
Figure 50. Manufacturing Cost Structure of Recombinant Human Follitropin
Figure 51. Manufacturing Process Analysis of Recombinant Human Follitropin
Figure 52. Recombinant Human Follitropin Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed